185 related articles for article (PubMed ID: 36302175)
21. SDHC epi-mutation testing in gastrointestinal stromal tumours and related tumours in clinical practice.
Casey RT; Ten Hoopen R; Ochoa E; Challis BG; Whitworth J; Smith PS; Martin JE; Clark GR; Rodger F; Maranian M; Allinson K; Madhu B; Roberts T; Campos L; Anstee J; Park SM; Marker A; Watts C; Bulusu VR; Giger OT; Maher ER
Sci Rep; 2019 Jul; 9(1):10244. PubMed ID: 31308404
[TBL] [Abstract][Full Text] [Related]
22. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
23. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.
Williamson SR; Eble JN; Amin MB; Gupta NS; Smith SC; Sholl LM; Montironi R; Hirsch MS; Hornick JL
Mod Pathol; 2015 Jan; 28(1):80-94. PubMed ID: 25034258
[TBL] [Abstract][Full Text] [Related]
24. Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations.
King KS; Prodanov T; Kantorovich V; Fojo T; Hewitt JK; Zacharin M; Wesley R; Lodish M; Raygada M; Gimenez-Roqueplo AP; McCormack S; Eisenhofer G; Milosevic D; Kebebew E; Stratakis CA; Pacak K
J Clin Oncol; 2011 Nov; 29(31):4137-42. PubMed ID: 21969497
[TBL] [Abstract][Full Text] [Related]
25. Screening of a Large Cohort of Asymptomatic SDHx Mutation Carriers in Routine Practice.
Saie C; Buffet A; Abeillon J; Drui D; Leboulleux S; Bertherat J; Zenaty D; Storey C; Borson-Chazot F; Burnichon N; Vincent M; Favier J; Baudin E; Giraud S; Gimenez-Roqueplo AP; Amar L; Lussey-Lepoutre C
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1301-e1315. PubMed ID: 33247927
[TBL] [Abstract][Full Text] [Related]
26. The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.
Schaefer IM; Hornick JL; Bovée JVMG
Lab Invest; 2018 Apr; 98(4):414-426. PubMed ID: 29339836
[TBL] [Abstract][Full Text] [Related]
27. Germline SDHB mutations and familial renal cell carcinoma.
Ricketts C; Woodward ER; Killick P; Morris MR; Astuti D; Latif F; Maher ER
J Natl Cancer Inst; 2008 Sep; 100(17):1260-2. PubMed ID: 18728283
[TBL] [Abstract][Full Text] [Related]
28. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
29. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers.
Muller M; Ferlicot S; Guillaud-Bataille M; Le Teuff G; Genestie C; Deveaux S; Slama A; Poulalhon N; Escudier B; Albiges L; Soufir N; Avril MF; Gardie B; Saldana C; Allory Y; Gimenez-Roqueplo AP; Bressac-de Paillerets B; Richard S; Benusiglio PR
Clin Genet; 2017 Dec; 92(6):606-615. PubMed ID: 28300276
[TBL] [Abstract][Full Text] [Related]
30. Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4.
Gill AJ; Pachter NS; Clarkson A; Tucker KM; Winship IM; Benn DE; Robinson BG; Clifton-Bligh RJ
N Engl J Med; 2011 Mar; 364(9):885-6. PubMed ID: 21366490
[No Abstract] [Full Text] [Related]
31. SDH-related pheochromocytoma and paraganglioma.
Kantorovich V; King KS; Pacak K
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):415-24. PubMed ID: 20833333
[TBL] [Abstract][Full Text] [Related]
32. Current management of succinate dehydrogenase-deficient gastrointestinal stromal tumors.
Neppala P; Banerjee S; Fanta PT; Yerba M; Porras KA; Burgoyne AM; Sicklick JK
Cancer Metastasis Rev; 2019 Sep; 38(3):525-535. PubMed ID: 31773431
[TBL] [Abstract][Full Text] [Related]
33. Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor.
Killian JK; Kim SY; Miettinen M; Smith C; Merino M; Tsokos M; Quezado M; Smith WI; Jahromi MS; Xekouki P; Szarek E; Walker RL; Lasota J; Raffeld M; Klotzle B; Wang Z; Jones L; Zhu Y; Wang Y; Waterfall JJ; O'Sullivan MJ; Bibikova M; Pacak K; Stratakis C; Janeway KA; Schiffman JD; Fan JB; Helman L; Meltzer PS
Cancer Discov; 2013 Jun; 3(6):648-57. PubMed ID: 23550148
[TBL] [Abstract][Full Text] [Related]
34. The association of genitourinary cancer among Saudi patients with gastrointestinal stromal tumors and a systematic literature review.
Seyam R; Chaer KA; Abouelkhair A; Almouh A; Alzahrani O; Sayed AG; Alghafees M; Alhamidi RA; Al-Gonaim A; Al-Hussain T; Amin TM; Altaweel W
Sci Rep; 2023 Mar; 13(1):4325. PubMed ID: 36922517
[TBL] [Abstract][Full Text] [Related]
35. A Novel SDHB IVS2-2A>C Mutation Is Responsible for Hereditary Pheochromocytoma/Paraganglioma Syndrome.
Yamanaka M; Shiga K; Fujiwara S; Mizuguchi Y; Yasuda S; Ishizawa K; Saiki Y; Higashi K; Ogawa T; Kimura N; Horii A
Tohoku J Exp Med; 2018 Jun; 245(2):99-105. PubMed ID: 29925701
[TBL] [Abstract][Full Text] [Related]
36. Hereditary pheochromocytoma/paraganglioma syndrome with a novel mutation in the succinate dehydrogenase subunit B gene in a Japanese family: two case reports.
Hirose R; Tsurutani Y; Sugisawa C; Inoue K; Suematsu S; Nagata M; Hasegawa N; Kakuta Y; Yonamine M; Takekoshi K; Kimura N; Saito J; Nishikawa T
J Med Case Rep; 2021 May; 15(1):282. PubMed ID: 34020699
[TBL] [Abstract][Full Text] [Related]
37. Genetics of hereditary head and neck paragangliomas.
Boedeker CC; Hensen EF; Neumann HP; Maier W; van Nederveen FH; Suárez C; Kunst HP; Rodrigo JP; Takes RP; Pellitteri PK; Rinaldo A; Ferlito A
Head Neck; 2014 Jun; 36(6):907-16. PubMed ID: 23913591
[TBL] [Abstract][Full Text] [Related]
38. SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.
Jochmanova I; Wolf KI; King KS; Nambuba J; Wesley R; Martucci V; Raygada M; Adams KT; Prodanov T; Fojo AT; Lazurova I; Pacak K
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1421-1435. PubMed ID: 28374168
[TBL] [Abstract][Full Text] [Related]
39. A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma.
MacFarlane J; Seong KC; Bisambar C; Madhu B; Allinson K; Marker A; Warren A; Park SM; Giger O; Challis BG; Maher ER; Casey RT
Clin Endocrinol (Oxf); 2020 Nov; 93(5):528-538. PubMed ID: 32686200
[TBL] [Abstract][Full Text] [Related]
40. Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects.
Kuroda N; Yorita K; Nagasaki M; Harada Y; Ohe C; Jeruc J; Raspollini MR; Michal M; Hes O; Amin MB
Pol J Pathol; 2016 Mar; 67(1):3-7. PubMed ID: 27179267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]